The fling with the exchange said, “We enclose the audited standalone financial results of the Company and audited consolidated financial results of the Company and its subsidiaries for the quarter and six-month period ended September 30, 2025, under Indian Accounting Standards, which have been approved and taken on record at a meeting of the Board of Directors of the Company held today.”
Also Read | MF Tracker: Can this international fund which gave 13% return last month sustain momentum?
“We would like to inform you that at the Board Meeting held today, the Directors have declared a second interim dividend of INR 11 per Equity Share of INR 1 each of the Company,” it further added.
The company has reported a 1.4% growth in its Q2 net profit at Rs 12,075 crore versus Rs 11,909 crore in the year ago period.
The profit after tax (PAT) is attributable to the shareholders of the company and was below Street’s estimates of Rs 12,573 crore. The revenue from operations stood at Rs 65,799, up 2.4% over Rs 64,259 crore posted in the corresponding quarter of the last financial year.The company’s revenue was up 3.7% on a sequential basis compared to Rs 63,437 crore reported in Q1FY26 while increasing 0.8% in Constant Currency.Also Read | Radhika Gupta on how a 50:50 gold-silver mix worked for the industry’s first FoF
TCS’ international revenue grew 0.6% QoQ in constant currency while company claimed a broad-based growth across verticals, led by continued momentum in BFSI (+1.1% QoQ CC), TSS (+1.8% QoQ CC). The Life Sciences and Healthcare segment reported a 3.4% QoQ CC growth while manufacturing rose 1.6% QoQ CC amidst industry specific challenges. The CMI segment rose 0.8% QoQ.
The operating margin stood at 25.2% which was an expansion of 70 bps QoQ. The net income was up 8.4% YoY while the net margin stood at 19.6%
as a Reliable and Trusted News Source